Diabetes, Vol 37, Issue 1 28-32, Copyright © 1988 by American Diabetes Association

ARTICLES

Additive hypoglycemic effects of drugs that modify free-fatty acid metabolism by different mechanisms in rats with streptozocin-induced diabetes

GM Reaven, H Chang and BB Hoffman
Department of Medicine, Stanford University School of Medicine, Palo Alto, California.

In this study the effect of two drugs [etomoxir and nicotinic acid (NA)] on plasma glucose, free-fatty acid (FFA), and triglyceride (TG) concentrations was determined in rats with streptozocin (STZ)-induced diabetes. The two compounds modify FFA metabolism by different mechanisms, etomoxir (ethyl-2-[6-(4-cholorophenoxyl)-hexyl]oxirane-2-carboxylate) by inhibiting hepatic fatty acid oxidation, and NA by inhibiting lipolysis in adipose tissue. Diabetes was induced in male Sprague-Dawley rats, weighing approximately 400 g, by STZ injection (30 mg/kg i.v.), and the metabolic effects of the two drugs were studied 7-10 days later. The acute administration of either etomoxir or NA lowered plasma glucose concentrations in diabetic rats by approximately 150 mg/dl (P less than .001) in 4 h. However, the two drugs differed dramatically in their effects on plasma FFA and TG concentrations. Specifically, etomoxir produced striking increases in plasma FFA and TG concentrations, whereas NA administration caused a marked decrease. However, when NA was given in conjunction with etomoxir, NA prevented the increase in plasma FFA and TG concentration seen with etomoxir; the combination of NA and etomoxir approximately doubled the decrease in plasma glucose concentration produced by NA or etomoxir when given alone. Because plasma insulin concentrations did not change in response to either drug, whether administered singly or in combination, these metabolic effects do not result from a change in insulin secretion. These results suggest that modulation of FFA metabolism at the level of the adipocyte or the liver can have dramatic effects on carbohydrate and lipid metabolism.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				S. Viswanadha and C. Londos Optimized conditions for measuring lipolysis in murine primary adipocytes J. Lipid Res., August 1, 2006; 47(8): 1859 - 1864. [Abstract] [Full Text] [PDF]

				A. J. Murray, M. Panagia, D. Hauton, G. F. Gibbons, and K. Clarke Plasma Free Fatty Acids and Peroxisome Proliferator-Activated Receptor {alpha} in the Control of Myocardial Uncoupling Protein Levels Diabetes, December 1, 2005; 54(12): 3496 - 3502. [Abstract] [Full Text] [PDF]

				L. Lee, J. Horowitz, and M. Frenneaux Metabolic manipulation in ischaemic heart disease, a novel approach to treatment Eur. Heart J., April 2, 2004; 25(8): 634 - 641. [Abstract] [Full Text] [PDF]

				S. F. Bernard, E. Mioskowski, and R. Groscolas Blockade of fatty acid oxidation mimics phase II-phase III transition in a fasting bird, the king penguin Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2002; 283(1): R144 - R152. [Abstract] [Full Text] [PDF]

				H. Ruan and H. J. Pownall Overexpression of 1-Acyl-Glycerol-3-Phosphate Acyltransferase-{alpha} Enhances Lipid Storage in Cellular Models of Adipose Tissue and Skeletal Muscle Diabetes, February 1, 2001; 50(2): 233 - 240. [Abstract] [Full Text]

				J. McGarry What if Minkowski had been ageusic? An alternative angle on diabetes Science, October 30, 1992; 258(5083): 766 - 770. [Abstract] [PDF]